Shenouda Maged bought RLMD
September 9, 2026 · Form 4 insider transaction
Shenouda Maged bought 120,200 shares of Relmada Therapeutics, Inc. at $4.20 per share, a transaction worth $504.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.; Purchase prices range from $4.16 to $4.20 per share, inclusive.